Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, "Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012" provides data on the Small-Cell Lung Cancer/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small-Cell Lung Cancer/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Small-Cell Lung Cancer/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Small-Cell Lung Cancer/Impaired Glucose Tolerance Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Small-Cell Lung Cancer/Impaired Glucose Tolerance, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Small-Cell Lung Cancer 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Small-Cell Lung Cancer 25
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
Bristol-Myers Squibb Company 38
Clinical Trial Overview of Bristol-Myers Squibb Company 38
Celgene Corporation 39
Clinical Trial Overview of Celgene Corporation 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
ZIOPHARM Oncology, Inc. 41
Clinical Trial Overview of ZIOPHARM Oncology, Inc. 41
ImmunoGen, Inc. 42
ImmunoGen, Inc. 42
Clinical Trial Overview of ImmunoGen, Inc. 42
Amgen Inc. 43
Clinical Trial Overview of Amgen Inc. 43
Bayer Inc. 44
Clinical Trial Overview of Bayer Inc. 44
Abbott Laboratories 45
Clinical Trial Overview of Abbott Laboratories 45
Sanofi 46
Clinical Trial Overview of Sanofi 46
Nippon Kayaku Co., Ltd. 47
Clinical Trial Overview of Nippon Kayaku Co., Ltd. 47
Astex Pharmaceuticals, Inc. 48
Clinical Trial Overview of Astex Pharmaceuticals, Inc. 48
Merck KGaA 49
Clinical Trial Overview of Merck KGaA 49
Poniard Pharmaceuticals, Inc. 50
Clinical Trial Overview of Poniard Pharmaceuticals, Inc. 50
UAB Health System 51
Clinical Trial Overview of UAB Health System 51
CHONG KUN DANG PHARMACEUTICAL CORP. 52
Clinical Trial Overview of CHONG KUN DANG PHARMACEUTICAL CORP. 52
Cephalon, Inc. 53
Clinical Trial Overview of Cephalon, Inc. 53
ImClone LLC 54
Clinical Trial Overview of ImClone LLC 54
Novartis AG 55
Clinical Trial Overview of Novartis AG 55
Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
The University of Texas M. D. Anderson Cancer Center 56
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
Southeastern Medical Oncology Center 57
Clinical Trial Overview of Southeastern Medical Oncology Center 57
Sarah Cannon Research Institute 58
Clinical Trial Overview of Sarah Cannon Research Institute 58
H. Lee Moffitt Cancer Center & Research Institute 59
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 59
Dana-Farber Cancer Institute 60
Clinical Trial Overview of Dana-Farber Cancer Institute 60
Wake Forest University 61
Clinical Trial Overview of Wake Forest University 61
Memorial Sloan Kettering Cancer Center 62
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62
Maastricht Radiation Oncology 63
Clinical Trial Overview of Maastricht Radiation Oncology 63
Mayo Clinic 64
Clinical Trial Overview of Mayo Clinic 64
Fox Chase Cancer Center 65
Clinical Trial Overview of Fox Chase Cancer Center 65
University of Michigan Comprehensive Cancer Center 66
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 66
University of Colorado 67
Clinical Trial Overview of University of Colorado 67
UCLA's Jonsson Comprehensive Cancer Center 68
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 68
Stanford University 69
Clinical Trial Overview of Stanford University 69
Roswell Park Cancer Institute 70
Clinical Trial Overview of Roswell Park Cancer Institute 70
Case Comprehensive Cancer Center 71
Clinical Trial Overview of Case Comprehensive Cancer Center 71
UH Seidman Cancer Center 72
Clinical Trial Overview of UH Seidman Cancer Center 72
Vanderbilt-Ingram Cancer Center 73
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 73
Norris Cotton Cancer Center 74
Clinical Trial Overview of Norris Cotton Cancer Center 74
Tohoku University 75
Clinical Trial Overview of Tohoku University 75
Five Key Clinical Profiles 76
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95
List of Tables
List of Tables
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Small-Cell Lung Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Small-Cell Lung Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18
Small-Cell Lung Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Small-Cell Lung Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20
Small-Cell Lung Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33
Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 35
GlobalData Methodology 93
Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2012 published by GlobalData in June 30, 2012. This report consists of Pages: 95 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
